Company Overview of CareDx, Inc
CareDx, Inc, a commercial stage company, develops, markets, and delivers diagnostic surveillance solutions for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. Its commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a blood-based test used to monitor heart transplant recipients for acute cellular rejection. The company markets its AlloMap solution to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners in the United States, Canada, and Europe. The company was formerly known as XDx...
3260 Bayshore Boulevard
Brisbane, CA 94005
Founded in 1998
Key Executives for CareDx, Inc
Chief Executive Officer, President and Director
Total Annual Compensation: $547.6K
Chief Medical Officer and Executive Vice President
Total Annual Compensation: $524.5K
Chief Compliance Officer and Chief Business Officer
Total Annual Compensation: $445.5K
Compensation as of Fiscal Year 2014.
CareDx, Inc Key Developments
CareDx, Inc Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 04:30 PM
May 27 15
CareDx, Inc Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 04:30 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Kenneth E. Ludlum, Chief Financial Officer, Peter Maag, Chief Executive Officer, President and Director.
CareDx, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015; Confirms Earnings Guidance for the Full Year of 2015
May 12 15
CareDx Inc. announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total revenue of $7,216,000 against $5,924,000 a year ago. Loss from operations was $1,391,000 against $227,000 a year ago. Net loss was $2,272,000 against $1,304,000 a year ago. Basic and diluted net loss per share was $0.19 against $1.29 a year ago.
The company confirmed revenue for the full year of 2015 is expected to be in the range of $28 to $30 million.
CareDx, Inc Presents at JMP Securities Life Sciences Conference, Jun-23-2015 03:30 PM
May 7 15
CareDx, Inc Presents at JMP Securities Life Sciences Conference, Jun-23-2015 03:30 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States. Speakers: Kenneth E. Ludlum, Chief Financial Officer, Peter Maag, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 30, 2015